AstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal
3 sources·Updated August 2, 2026
AstraZeneca Bristol Myers deal
Covered by 3 sources
- CNBC Top News·4h agoAstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
Read at CNBC Top News → - Bloomberg Business·8h agoAstraZeneca, Bristol Myers Squibb Held Tie-Up Talks, FT Says
AstraZeneca Plc and Bristol Myers Squibb Co. have held discussions about a deal that would combine the two drugmakers into a single company, the Financial Times reported, citing people familiar with the matter.
Read at Bloomberg Business → - Financial Times·8h agoAstraZeneca holds talks with Bristol Myers Squibb on $400bn megadeal
Tie-up would create one of the world’s biggest drugmakers
Read at Financial Times →
